This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Helsingin Yliopisto, Teknologian Tutkimuskeskus VTT Oy. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Alistair King: Innovator in Biomaterials and Bicyclic Guanidines
Introduction
Alistair King is a notable inventor based at Helsingin Yliopisto in Finland. With a keen focus on the intersection of biomaterials and chemical synthesis, King has contributed significantly to the field through his inventions.
Latest Patents
King holds two patents that showcase his innovative capabilities. The first is a **Method of joining polymeric biomaterials**, which involves applying an ionic liquid onto the surfaces of hydrophilic polymeric biomaterials. By pressing these surfaces together and subsequently removing the ionic liquid, this method results in a product composed entirely of biomaterial, without any remnants of synthetic polymers or chemicals. His second patent, **Method for preparing a bicyclic guanidine and its derivatives**, focuses on producing triazabicyclodecene (TBD) and its derivatives, particularly methyl triazabicyclodecene (MTBD) and MTBD-derived ionic liquids. This method has further applications in cellulose dissolution and processing.
Career Highlights
Alistair King has built a significant career at prominent organizations, including Helsingin Yliopisto and VTT Technical Research Centre of Finland. His work has primarily revolved around the integration of chemistry and biotechnology, driving forward innovative solutions in both fields.
Collaborations
Throughout his career, King has collaborated with notable colleagues such as Ilkka Kilpeläinen and Jussi Helminen. These partnerships have likely contributed to his successful patent applications and advancements in research.
Conclusion
In summary, Alistair King embodies the spirit of innovation with his significant contributions to biomaterials and chemical synthesis. His patents reflect a commitment to creating sustainable and efficient technologies that could have lasting impacts on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

